XLONSEED
Market cap3mUSD
Dec 20, Last price
1.60GBP
1D
-3.03%
1Q
3.23%
Jan 2017
-85.29%
IPO
-99.86%
Name
Seed Innovations Ltd
Chart & Performance
Profile
Seed Innovations Limited, is a venture capital firm specializing in early stage investments. The firm prefers to focus on investments in innovative lifestyle, wellness, health, medical cannabis the technology sector and life sciences, medical cannabis and pharmaceuticals. It typically invests in North America and Europe but will consider investments elsewhere in the world. The firm can take a minority position to full ownership in its investments. It considers investments in companies with significant intellectual property rights. Seed Innovations Limited is based in Guernsey, Channel Islands.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | 2015‑03 | |
Income | ||||||||||
Revenues | (1,105) -70.83% | (3,788) 3.61% | (3,656) -150.29% | |||||||
Cost of revenue | 745 | 648 | 806 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (1,850) | (4,436) | (4,462) | |||||||
NOPBT Margin | 167.42% | 117.11% | 122.05% | |||||||
Operating Taxes | (4,459) | (4,510) | ||||||||
Tax Rate | ||||||||||
NOPAT | (1,850) | 23 | 48 | |||||||
Net income | (2,120) -52.46% | (4,459) -1.13% | (4,510) -169.09% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | (308) | |||||||||
BB yield | 7.56% | |||||||||
Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 67 | 42 | ||||||||
Net debt | (11,206) | (16,049) | (20,446) | |||||||
Cash flow | ||||||||||
Cash from operating activities | (3,253) | (670) | (927) | |||||||
CAPEX | ||||||||||
Cash from investing activities | 7,478 | (285) | 128 | |||||||
Cash from financing activities | (308) | |||||||||
FCF | (4,248) | 23 | 48 | |||||||
Balance | ||||||||||
Cash | 3,885 | 30 | 922 | |||||||
Long term investments | 7,321 | 16,019 | 19,524 | |||||||
Excess cash | 11,261 | 16,238 | 20,629 | |||||||
Stockholders' equity | 13,604 | 16,032 | 20,461 | |||||||
Invested Capital | 2,343 | 1 | ||||||||
ROIC | 27.63% | |||||||||
ROCE | ||||||||||
EV | ||||||||||
Common stock shares outstanding | 208,840 | 212,747 | 212,747 | |||||||
Price | 0.02 1.30% | 0.02 -58.38% | 0.05 -44.28% | |||||||
Market cap | 4,072 -0.56% | 4,095 -58.38% | 9,840 -32.10% | |||||||
EV | (7,134) | (11,954) | (10,606) | |||||||
EBITDA | (1,850) | (4,436) | (4,462) | |||||||
EV/EBITDA | 3.86 | 2.69 | 2.38 | |||||||
Interest | ||||||||||
Interest/NOPBT |